MPO Staff03.03.22
Bio-Rad Laboratories Inc. has shuffled its executive team to account for a retirement.
The company has named Simon May, Ph.D., as executive vice president and president of the Life Science Group, succeeding Annette Tumolo, who retired. May now leads and manages the overall strategy and business direction for the company's Life Science Group global operations.
May has spent the last two years in charge of Bio-Rad’s Digital Biology Group, leading the division through two acquisitions, IP litigation and several product launches. Prior to his role within DBG, he served as senior vice president, global commercial operations, Americas, with oversight of a $1 billion business and more than 1,000 employees. May joined Bio-Rad in September 2014 as vice president, North America Sales and Service, Life Science.
Before his Bio-Rad tenure, May spent seven years at Thermo Fisher Scientific in various leadership roles in sales and product/portfolio management.
May earned a doctorate degree in molecular biology and acquired hands-on expertise in molecular biology and tissue culture techniques as a Postdoctoral Research Fellow at the University of Liverpool.
"We are pleased to promote Simon and believe that his strong experience and expertise, coupled with his strengths in building high-performing teams at Bio-Rad, make him ideally suited for this important position," said Andrew Last, Bio-Rad executive vice president and chief operating officer. "We would also like to thank Annette for her many years of valuable contributions to the growth and success of Bio-Rad, and we wish her the best in her retirement."
Bio-Rad Laboratories Inc. develops, manufactures, and markets products for the life science research and clinical diagnostic markets. Its customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, Calif., and has a global network of operations with more than 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020.
The company has named Simon May, Ph.D., as executive vice president and president of the Life Science Group, succeeding Annette Tumolo, who retired. May now leads and manages the overall strategy and business direction for the company's Life Science Group global operations.
May has spent the last two years in charge of Bio-Rad’s Digital Biology Group, leading the division through two acquisitions, IP litigation and several product launches. Prior to his role within DBG, he served as senior vice president, global commercial operations, Americas, with oversight of a $1 billion business and more than 1,000 employees. May joined Bio-Rad in September 2014 as vice president, North America Sales and Service, Life Science.
Before his Bio-Rad tenure, May spent seven years at Thermo Fisher Scientific in various leadership roles in sales and product/portfolio management.
May earned a doctorate degree in molecular biology and acquired hands-on expertise in molecular biology and tissue culture techniques as a Postdoctoral Research Fellow at the University of Liverpool.
"We are pleased to promote Simon and believe that his strong experience and expertise, coupled with his strengths in building high-performing teams at Bio-Rad, make him ideally suited for this important position," said Andrew Last, Bio-Rad executive vice president and chief operating officer. "We would also like to thank Annette for her many years of valuable contributions to the growth and success of Bio-Rad, and we wish her the best in her retirement."
Bio-Rad Laboratories Inc. develops, manufactures, and markets products for the life science research and clinical diagnostic markets. Its customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, Calif., and has a global network of operations with more than 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020.